Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001520262-25-000004
Filing Date
2025-09-23
Accepted
2025-09-23 19:43:52
Documents
2
Period of Report
2025-09-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1471
2 POWER OF ATTORNEY (PUBLIC): SEPTEMBER 2025 POA doc1.txt EX-24 5523
  Complete submission text file 0001520262-25-000004.txt   8638
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Issuer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE, SUITE 320 LEXINGTON MA 02421
Business Address
Reed Joshua (Reporting) CIK: 0001746541 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35299 | Film No.: 251334945